--- title: "Qualified Persons Requirement for the University of Birmingham" ocid: "ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581.json" source: "Contracts Finder" current_stage: "Tender" buyer: "UNIVERSITY OF BIRMINGHAM" published: "2018-05-25" --- # Qualified Persons Requirement for the University of Birmingham Buyer: UNIVERSITY OF BIRMINGHAM Current stage: Tender OCID: ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581.json) ## Summary The University of Birmingham is currently undertaking a procurement process for the project titled "Qualified Persons Requirement." This tender falls within the healthcare industry category, specifically focusing on services related to research laboratory and medical analysis. The contract is set to commence on 1 August 2018 and will run until 31 July 2020. The tender period concludes on 22 June 2018, and the services will be delivered to the University’s facilities located in Edgbaston, Birmingham, West Midlands, United Kingdom. This tender presents a significant opportunity for small and medium-sized enterprises (SMEs) specialising in research laboratory services and medical analysis to engage in high-level clinical and experimental projects. Businesses with expertise in advanced therapies, clinical trial management, and GMP-compliant manufacturing are particularly well-suited to compete for this contract. By collaborating with an esteemed institution like the University of Birmingham, winning bidders can enhance their reputational capital while contributing to groundbreaking medical research and development initiatives. ## Notice The University of Birmingham is a world-leading institution for the generation of pre-clinical breakthroughs, delivery of clinical trials, and associated health and methodological research. Its advantages stem from close integration with nearby NHS Trusts, particularly with its key partner the University Hospitals Birmingham NHS Foundation Trust (UHBFT). It has access to one of the largest and most diverse patient catchment regions in Europe, alongside a wide range of well-characterised patient cohorts. Capabilities and expertise in advanced therapies are based around excellent under-pinning basic science, good pre-clinical models of disease, manufacturing facilities, translational facilities and clinical trials expertise. The University of Birmingham and University Hospitals Birmingham jointly host significant infrastructure for experimental medicine and early phase trials including the millennial Wellcome Trust Clinical Research Facility, the Experimental Cancer Medicine Centre and NIHR Biomedical Research Unit for Hepatology. The BCCT hosts the Early Drug Development team with expertise in industry-sponsored and academic-led trials, adult and paediatric oncology, solid cancers and haematology, liver medicine, molecularly targeted therapy, cellular immunotherapy and gene therapy. It has dedicated, integrated and expanding facilities for clinical assessment and treatment, whole body metabolic measurement, pharmacy, imaging and GCP-compliant laboratories. The Advanced Therapies Facility (ATF) is situated within the College of Medical and Dental Sciences, and comprises the Human Biomaterials Resource Centre (an HTA licensed ethically approved human sample repository) and the GMP Manufacturing Facility (GMP-MF). The GMP-MF holds a Manufacturer's Licence from the MHRA which covers the production of Advanced Therapy Medicinal Products (ATMPs) within the Cell Therapy Suite (CTS) and faecal microbiota within the Microbiome Treatment Centre. In addition, a Specials licence allows for the manufacture of products for use for selected patients outside clinical trial settings. The unit has a robust personnel and governance infrastructure with a dedicated team who can provide expertise and advice on protocol development, and who deliver all aspects of technology transfer, process validation, manufacture and Quality Control. Within the CTS there are two parallel clean room suites cascading from Grade D through to Grade B classification. Grade B areas contain Class 2 safety cabinets or isolators. The facility also contains state-of-the-art cell sorting technology including CliniMACS and Prodigy systems, a dedicated QC laboratory, and ample GMP compliant storage areas containing freezers and liquid nitrogen tanks. The unit is joined onto the adjacent NIHR/Wellcome Trust Clinical Research Facility where manufactured products are administered to patients in an appropriately staffed and monitored clinical environment. Currently... Additional information: Is a Recurrent Procurement Type? : No ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/16af05df-2c81-46b6-85b6-a4829f3312cd | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Not Specified | | Procurement method details | Other - | | Tender suitability | SME | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 25 May 2018 | | Submission deadline | 22 Jun 2018 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | 31 Jul 2018 - 31 Jul 2020 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Not specified | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | UNIVERSITY OF BIRMINGHAM | | Locality | EDGBASTON | | Post town | Birmingham | | Postcode | B15 2TT | | Country | England | | ITL 1 | TLG West Midlands (England) | | ITL 2 | TLG3 West Midlands | | ITL 3 | TLG31 Birmingham | | Local authority | Birmingham | | Electoral ward | Edgbaston | | Westminster constituency | Birmingham Edgbaston | | Delivery location | TLG West Midlands (England) | ## CPV Codes ### Divisions - 73 - Research and development services and related consultancy services - 85 - Health and social work services - 98 - Other community, social and personal services ### Codes - 73111000 - Research laboratory services - 85148000 - Medical analysis services - 98110000 - Services furnished by business, professional and specialist organisations ## Release History - 25 May 2018 at 16:23 - Tender - Tender Notice - https://www.contractsfinder.service.gov.uk/Notice/16af05df-2c81-46b6-85b6-a4829f3312cd ## Documents - https://www.contractsfinder.service.gov.uk/Notice/16af05df-2c81-46b6-85b6-a4829f3312cd 25th May 2018 - Opportunity notice on Contracts Finder - https://in-tendhost.co.uk/universityofbirmingham/aspx/ Additional information on how to apply for this contract ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-c6baff3f-2952-407b-ac2d-85167e102581.json.